Form D — PLEOPHARMA, INC.
0001801323-26-000001 · filed Aug 10, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $15,000,000
- Total sold
- $5,500,000
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- PLEOPHARMA, INC.
- CIK
- 1801323
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 518 KIMBERTON RD.
PHOENIXVILLE, PA 19460 - Phone
- (610) 937-2882
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ginger Constantine · Executive OfficerPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Jay Constantine · Executive OfficerPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Robert Finizio · Executive OfficerPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Paul Bisaro · DirectorPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Tommy Thompson · DirectorPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Sarah Hassan · DirectorPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Brij Sharma · DirectorPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Kyle Mowitz · DirectorPhoenixville, PA Find on LinkedIn ↗
-
Kyle Tomlin · DirectorPhoenixville, PA 19460, PA Find on LinkedIn ↗
-
Poche Thomas · Executive OfficerPhoenixville, PA Find on LinkedIn ↗
-
Daniel Cartwright · Executive OfficerPhoenixville, PA Find on LinkedIn ↗
-
McInerney Timothy · DirectorPhoenixville, PA 19460, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗